Skip to content
MedsAcross

Brand family

Optiray 300

Ioversol · Liebel-Flarsheim
United States
Presentations
5
Markets
1

Optiray 300 is a brand of Ioversol marketed by Liebel-Flarsheim, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Ioversol
Brand owner
Liebel-Flarsheim
Registered in
United States
Strengths and forms
127200 mg/200 mL injection, 31800 mg/50 mL injection, 47700 mg/75 mL injection, 63600 mg/100 mL injection, 95400 mg/150 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Optiray 300 127200 mg/200 mL injectionIntra-arterial, intravenousLiebel-FlarsheimUS FDAAvailable on request
Optiray 300 31800 mg/50 mL injectionIntra-arterial, intravenousLiebel-FlarsheimUS FDAAvailable on request
Optiray 300 47700 mg/75 mL injectionIntra-arterial, intravenousLiebel-FlarsheimUS FDAAvailable on request
Optiray 300 63600 mg/100 mL injectionIntra-arterial, intravenousLiebel-FlarsheimUS FDAAvailable on request
Optiray 300 95400 mg/150 mL injectionIntra-arterial, intravenousLiebel-FlarsheimUS FDAAvailable on request

Equivalent brands

Other brands of Ioversol.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Optiray 300

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.